23 July 2012
NUH continues to invest in world-class cancer treatment
NUH is continuing to invest in its treatment of cancer patients
with the installation of a new £1.5m Image Guided Radiotherapy
(IGRT) linac machine.
The new equipment, which will be delivered in August, enables
patients to be given targeted cancer treatment minimising side
effects for patients.
IGRT machines allow radiographers to deliver more accurate
treatment by producing an image of the inside of the patient so
radiation doses can be targeted more precisely.
The machine, which is believed to be only the third of its type
to be installed in the country, will also enable radiographers to
carry out more complex treatments in shorter amounts of time.
The new equipment replaces a 10-year-old machine that had
reached the end of its operational life and will be the Trust's
fifth imaged guided linac machine.
In addition, NUH has invested in upgrading another four-year-old
linac machine ensuring that the Trust continues to deliver
world-class cancer treatment.
Dr Keith Langmack, Head of Clinical Radiotherapy Physics at NUH,
said: "The new machine means we are able to deliver
state-of-the-art radiotherapy services. The equipment has a CT
scanner onboard which the previous machine did not have and is the
Trust's fifth image guided machine.
"The machine is also more accurate and quicker which means the
patients spend less time in the machine."
Russell Hart, Radiotherapy Service Manager, said: "It is
excellent news for our patients that the Trust has the vision to
invest this money in radiotherapy. This follows the £21m spent on
the new radiotherapy centre opened at the City Hospital in
"This means we can continue to deliver world-class treatment for
our patients at a time when many trusts are not replacing equipment
due to financial pressures."
Radiotherapy is a significant component of the treatment of 40
per cent of all patients who are cured of their cancer. Timely
access to radiotherapy should improve cancer outcome and
Radiotherapy is more targeted than chemotherapy and less
invasive than surgery. As it is a more directed form of treatment
than chemotherapy there are fewer side effects on the rest of the
body and it can also spare patients from radical surgery. Also new
faster and more precise technologies reduce the need for long-term
treatment for common side effects.